Clinical Trial Update: Surgery Followed by Risk-Directed Post-Operative Adjuvant Therapy for HPV-Related Oropharynx Squamous Cell Carcinoma: "The Minimalist Trial (MINT)" [Phase 2]

View source ↗

Summary

Phase 2 results from the Minimalist Trial (MINT) evaluating surgery followed by risk-directed postoperative adjuvant therapy for HPV-related oropharyngeal squam…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hpv-related Oropharyngeal Squamous Cell Carcinoma

Snippet

Sponsor: Washington University School of Medicine | Conditions: HPV Related Oropharyngeal Squamous Cell Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2022-03-11